Targeted integration is being used to accelerate the development of consistent and stable cell lines. This approach is being applied in various biologics development platforms, with some companies launching next-generation platforms and others demonstrating efficient gene editing technologies. The use of targeted integration and related technologies, such as genome editing, appears to be advancing biopharmaceutical manufacturing and cell line development.